Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-06-07FDA Approved: RUGBY MOMETASONE FUROATE NASAL — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Mometasone Furoate Nasal (mometasone furoate) by Rugby Laboratories. The action pertains t…
-
FDA approval · 2024-06-05FDA Approved: AZELASTINE HCL — Original Application (Amneal Pharmaceuticals NY LLC)
ANDA approval for AZELASTINE HCL (azelastine) by Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2024-05-29FDA Approved: AZELASTINE HYDROCHLORIDE — Original Application (Allegiant Health)
FDA approved the original application for azelastine hydrochloride (generic) submitted by Allegiant Health.
-
FDA approval · 2024-05-22FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Allergy (loratadine) from Bayer HealthCare LLC., indicating an approved post-approval c…
-
FDA approval · 2024-05-17FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Montelukast Sodium from Rising Pharma Holdings, Inc., authorizing its generic montelukast pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-05-14FDA Approved: ALLERGY RELIEF-D — Original Application (HEB)
FDA approves ALLERGY RELIEF-D, a combination product of loratadine and pseudoephedrine sulfate, under an original application by HEB, for re…
-
FDA approval · 2024-05-10FDA Approved: 365 WHOLE FOODS MARKET FLUTICASONE PROPIONATE — Original Application (Whole Foods Market, Inc.)
The FDA approved the original application for 365 Whole Foods Market Fluticasone Propionate, a generic nasal spray containing fluticasone pr…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Washed Microbiota Transplantation for Allergic Rhinitis [NA]
Clinical trial investigating washed microbiota transplantation for allergic rhinitis is not yet recruiting, indicating early-stage research …
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Patient Satisfaction and Sensory Attributes Allergic Rhinitis Nasal Spray
Completed clinical trial evaluating patient satisfaction and sensory attributes of an allergic rhinitis nasal spray; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis [Phase 4]
Phase 4 trial updating the efficacy and safety of on-demand and continuous nasal spray administration for allergic rhinitis.
-
FDA approval · 2024-03-20FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved a generic diphenhydramine hydrochloride product through an Original Application (ANDA 218448) by Sagent Pharmaceuticals.
-
FDA approval · 2024-03-15FDA Approved: XHANCE — Supplemental Application (OptiNose US, Inc.)
FDA approved a supplemental application for XHANCE (fluticasone propionate) submitted by OptiNose US, Inc. The action updates the product la…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis. [Phase 4]
Phase 4 trial update investigating methylprednisolone injections for birch pollen–induced allergic rhinitis (hay fever).
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis [Phase 4]
A Phase 4 clinical trial update for bencycloquidium bromide nasal spray in moderate-severe persistent allergic rhinitis; current status unkn…
-
CLINICAL_TRIALS trial_result · 2024-03-01Clinical Trial Update: Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children [Phase 4]
Phase 4 study exploring optimal cetirizine dosing for allergic diseases in Chinese children.
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children. [Phase 3]
Phase 3 trial assessing DEP114 for efficacy and safety in children with moderate to severe persistent allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER) [Phase 3]
Phase 3 clinical trial update on MAZ-101 for persistent allergic rhinitis, focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Over-the-Counter Antihistamines & Heat Stress [Phase 4]
Phase 4 clinical trial update on over-the-counter antihistamines and heat-related conditions, with unclear status.
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Clinical Response to Rhinovirus Challenge [Phase 2]
Phase 2 clinical trial assessing clinical response to rhinovirus challenge in participants with asthma and allergic rhinitis has completed w…
-
FDA approval · 2024-01-04FDA Approved: ALLERGY RELIEF — Supplemental Application (WALMART INC. (see also Equate))
FDA approved a supplemental application for ALLERGY RELIEF containing fexofenadine HCl, manufactured by Walmart Inc.
-
FDA label_change · 2023-12-27FDA Approved: PROMETHAZINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Promethazine hydrochloride from Hikma Pharmaceuticals USA, authorizing changes to the product la…
-
FDA approval · 2023-12-15FDA Approved: TUXARIN — Supplemental Application (Mainpointe Pharmaceuticals)
FDA approved a supplemental application for TUXARIN (codeine phosphate and chlorpheniramine maleate) submitted by Mainpointe Pharmaceuticals…
-
FDA approval · 2023-12-05FDA Approved: PREDNISONE TABLETS, USP, 5 MG — Supplemental Application (Granulation Technology, Inc.)
FDA granted a supplemental approval for Prednisone Tablets, USP, 5 mg to authorize a granulation technology manufacturing change by Granulat…
-
FDA approval · 2023-11-27FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium from Dr. Reddy's Laboratories Limited under an ANDA, enabling a supplemental …
-
FDA approval · 2023-11-20FDA Approved: ASTEPRO ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for AStepro Allergy (azelastine HCl) from Bayer HealthCare LLC.